Teresa Waligórska

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

Inge M.W. Verberk, Els O. Misdorp, Jannet Koelewijn et al. · Alzheimer s & Dementia · 2021 · 222 citations · Full text

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

Whitley W. Aamodt, Teresa Waligórska, Junchao Shen et al. · Movement Disorders · 2021 · 166 citations · Full text

Qualification of a Surrogate Matrix-Based Absolute Quantification Method for Amyloid-β42 in Human Cerebrospinal Fluid Using 2D UPLC-Tandem Mass Spectrometry

Magdalena Korecka, Teresa Waligórska, Michal Figurski et al. · Journal of Alzheimer s Disease · 2014 · 107 citations · Full text

Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors

Ihab Hajjar, Zhiyi Yang, Maureen Okafor et al. · JAMA Network Open · 2022 · 96 citations · Full text

Derivation of cutoffs for the Elecsys^® amyloid β (1–42) assay in Alzheimer's disease

Leslie M. Shaw, Teresa Waligórska, Leona Fields et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2018 · 78 citations · Full text